![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
1. Du 21220
2. Du-21220
3. Du21220
4. Hydrochloride, Ritodrine
5. Pre Par
6. Pre-par
7. Prepar
8. Ritodrine
9. Yutopar
1. 23239-51-2
2. Ritodrine Hcl
3. Mls002153782
4. Ritodrinium
5. Nsc 291565
6. Smr001233166
7. Prestwick_763
8. Yutopar (tn)
9. Mfcd01657514
10. Ritodrin-hydrochloride
11. Ncgc00016773-01
12. Cas-23239-51-2
13. Dsstox_cid_25438
14. Dsstox_rid_80879
15. Dsstox_gsid_45438
16. Schembl122631
17. Ritodrine Hydrochloride- Bio-x
18. Chembl1201160
19. Dtxsid8045438
20. Chebi:32102
21. Hms1569e19
22. Tox21_110603
23. Ritodrine Hydrochloride (jp17/usp)
24. Akos025117464
25. Ac-3536
26. Ccg-220349
27. As-12194
28. Br164351
29. D01263
30. T72119
31. 239r512
32. J-015046
33. Ritodrine Hydrochloride, British Pharmacopoeia (bp) Reference Standard
34. Ritodrine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
35. 4-(2-(((1r,2s)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl)amino)ethyl)phenol Hydrochloride
36. 4-(2-((1r,2s)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-ylamino)ethyl)phenol Hydrochloride
37. 4-[2-[[(1r,2s)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]phenol;hydrochloride
38. Ritodrine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Molecular Weight | 323.8 g/mol |
---|---|
Molecular Formula | C17H22ClNO3 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 6 |
Exact Mass | 323.1288213 g/mol |
Monoisotopic Mass | 323.1288213 g/mol |
Topological Polar Surface Area | 72.7 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 284 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Adrenergic beta-2 Receptor Agonists
Compounds bind to and activate ADRENERGIC BETA-2 RECEPTORS. (See all compounds classified as Adrenergic beta-2 Receptor Agonists.)
Sympathomimetics
Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)
Tocolytic Agents
Drugs that prevent preterm labor and immature birth by suppressing uterine contractions (TOCOLYSIS). Agents used to delay premature uterine activity include magnesium sulfate, beta-mimetics, oxytocin antagonists, calcium channel inhibitors, and adrenergic beta-receptor agonists. The use of intravenous alcohol as a tocolytic is now obsolete. (See all compounds classified as Tocolytic Agents.)